Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Auris Medical advances phase IIb trial of AM-111 for acute sensorineural hearing loss

Jan. 24, 2011

Neramexane mesilate is safe and well tolerated in subjects with tinnitus

Jan. 18, 2011

Auris Medical advances phase IIb trial of AM-111 in acute sensorineural hearing loss

Nov. 26, 2010

GenVec achieves milestone in collaboration with Novartis

Sep. 15, 2010

Otonomy closes Series B financing

Sep. 1, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

GenVec and Novartis expand collaboration on hearing loss and balance disorders

Aug. 9, 2010

Otonomy secures funds to advance OTO-104 and OTO-203

June 16, 2010

Otonomy receives FDA clearance for trial in Meniere's disease

Feb. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...